GSA Capital Partners’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,283
Closed -$279K 1884
2024
Q3
$279K Sell
14,283
-47,780
-77% -$933K 0.02% 1255
2024
Q2
$1.15M Sell
62,063
-70,597
-53% -$1.31M 0.08% 414
2024
Q1
$1.86M Sell
132,660
-217,726
-62% -$3.05M 0.15% 140
2023
Q4
$2.97M Buy
350,386
+227,647
+185% +$1.93M 0.25% 33
2023
Q3
$1.1M Buy
122,739
+110,840
+932% +$991K 0.09% 348
2023
Q2
$103K Sell
11,899
-125
-1% -$1.08K 0.01% 1378
2023
Q1
$127K Sell
12,024
-30,978
-72% -$327K 0.01% 1328
2022
Q4
$1.46M Buy
43,002
+39,050
+988% +$1.32M 0.18% 74
2022
Q3
$190K Buy
3,952
+1,257
+47% +$60.4K 0.03% 1241
2022
Q2
$154K Buy
+2,695
New +$154K 0.02% 1137
2022
Q1
Sell
-702
Closed -$142K 1693
2021
Q4
$142K Sell
702
-804
-53% -$163K 0.02% 1280
2021
Q3
$406K Sell
1,506
-4,338
-74% -$1.17M 0.04% 824
2021
Q2
$1.5M Buy
+5,844
New +$1.5M 0.17% 122
2020
Q4
Sell
-1,994
Closed -$496K 1477
2020
Q3
$496K Buy
+1,994
New +$496K 0.08% 394
2018
Q4
Sell
-1,049
Closed -$959K 1611
2018
Q3
$959K Sell
1,049
-57
-5% -$52.1K 0.05% 706
2018
Q2
$810K Buy
+1,106
New +$810K 0.04% 881
2018
Q1
Sell
-949
Closed -$850K 1759
2017
Q4
$850K Sell
949
-3,091
-77% -$2.77M 0.05% 676
2017
Q3
$1.45M Buy
+4,040
New +$1.45M 0.1% 298
2017
Q1
Sell
-1,674
Closed -$308K 1911
2016
Q4
$308K Buy
+1,674
New +$308K 0.02% 1319
2016
Q2
Sell
-1,781
Closed -$367K 1850
2016
Q1
$367K Sell
1,781
-580
-25% -$120K 0.02% 1200
2015
Q4
$597K Sell
2,361
-658
-22% -$166K 0.03% 1044
2015
Q3
$496K Sell
3,019
-4,820
-61% -$792K 0.02% 1127
2015
Q2
$1.47M Sell
7,839
-441
-5% -$82.8K 0.06% 588
2015
Q1
$1.37M Buy
8,280
+5,618
+211% +$927K 0.05% 629
2014
Q4
$619K Sell
2,662
-1,429
-35% -$332K 0.04% 789
2014
Q3
$741K Buy
4,091
+2,570
+169% +$466K 0.04% 685
2014
Q2
$293K Buy
+1,521
New +$293K 0.01% 1436